Tuvirumab
From Self-sufficiency
Revision as of 18:06, 14 July 2010 by Citation bot 1 (Talk) (Citations: [Pu173] added: doi, first2, first3, first4, first5, first6, first7, first8. You can use this bot yourself! Report bugs here.)
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Template:Infobox drug/mab source |
| Target | hepatitis B virus |
| Identifiers | |
| ATC code | none |
Tuvirumab is a human monoclonal antibody for the treatment of patients with chronic hepatitis B. It has undergone Phase I clinical trials in 2001.[1][2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
- ↑ Heijtink, RA; Van Nunen, AB; Van Bergen, P; Ostberg, L; Osterhaus, AD; De Man, RA (2001). "Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes". Journal of medical virology. 64 (4): 427–34. doi:10.1002/jmv.1068. PMID 11468726.
- ↑ Van Nunen, AB; Baumann, M; Manns, MP; Reichen, J; Spengler, U; Marschner, JP; De Man, RA; International Study, Group (2001). "Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients". Liver. 21 (3): 207–12. doi:10.1034/j.1600-0676.2001.021003207.x. PMID 11422784.
Categories:
- Pages with script errors
- Articles which use infobox templates with no data rows
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs
